Progress in Personalized Psychiatric Therapy with the Example of Using Intranasal Oxytocin in PTSD Treatment
Post-traumatic stress disorder (PTSD) is a severe mental disorder that results in the frequent coexistence of other diseases, lowers patients’ quality of life, and has a high annual cost of treatment. However, despite the variety of therapeutic approaches that exist, some patients still do not achie...
Main Authors: | Sandra Szafoni, Magdalena Piegza |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/7/1067 |
Similar Items
-
Ameliorating Impact of Prophylactic Intranasal Oxytocin on Signs of Fear in a Rat Model of Traumatic Stress
by: Micah D. Renicker, et al.
Published: (2018-05-01) -
Intranasal oxytocin may improve odds of abstinence in cocaine-dependent patients: results from a preliminary study
by: Wilfrid Noël Raby, et al.
Published: (2022-03-01) -
Utility of Downstream Biomarkers to Assess and Optimize Intranasal Delivery of Oxytocin
by: Megan DuBois, et al.
Published: (2022-05-01) -
Preventing PTSD with oxytocin: effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals
by: Jessie L. Frijling
Published: (2017-01-01) -
Intranasal Administration for Pain: Oxytocin and Other Polypeptides
by: Vimala N. Bharadwaj, et al.
Published: (2021-07-01)